ASX:RAC Race Oncology (RAC) Stock Price, News & Analysis → “Retirement Secret” Showed 995% Gain Last Time We Shared It (From Stansberry Research) (Ad) Free RAC Stock Alerts Add Compare Share Share Today's Range N/A50-Day Range N/A52-Week Range N/AVolume76,322 shsAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Race Oncology alerts: Email Address Ad Stansberry Research“Retirement Secret” Showed 995% Gain Last Time We Shared ItCentral Banks Buying Gold in Record Numbers Most folks have completely missed the fact that the world's Central Banks have been quietly gobbling up as much gold as they can… Stacking it in their locked vaults on pallets in record numbers.Find out why right here (and see what you can do to get in too with just a few dollars). About Race Oncology Stock (ASX:RAC)Race Oncology Limited, a clinical stage global biotechnology company, focuses on cancer care. Its lead product, bisantrene, is a small molecule anthracene chemotherapeutic. The company is developing bisantrene to address the unmet need of patients across multiple oncology indications, exploring anti-cancer plus cardio-protection. It is also investigating the impact bisantrene and new molecules have on the m6A RNA pathway, following independent research describing bisantrene as the potent inhibitor of FTO (Fat mass and obesity-associated protein). The company is in collaboration with City of Hope, MD Anderson, Sheba City of Health, and UNC School of Medicine. The company was formerly known as Coronado Resources Limited and changed its name to Race Oncology Limited in July 2016. Race Oncology Limited was incorporated in 2011 and is based in Sydney, Australia.Read More Ad Stansberry Research“Retirement Secret” Showed 995% Gain Last Time We Shared ItCentral Banks Buying Gold in Record Numbers Most folks have completely missed the fact that the world's Central Banks have been quietly gobbling up as much gold as they can… Stacking it in their locked vaults on pallets in record numbers.Find out why right here (and see what you can do to get in too with just a few dollars). RAC Stock News HeadlinesApril 22, 2024 | finance.yahoo.comWill Race Oncology (ASX:RAC) Spend Its Cash Wisely?April 16, 2024 | msn.comPremier League suffers huge blow in race for extra Champions League spotApril 26, 2024 | Stansberry Research (Ad)“Retirement Secret” Showed 995% Gain Last Time We Shared ItCentral Banks Buying Gold in Record Numbers Most folks have completely missed the fact that the world's Central Banks have been quietly gobbling up as much gold as they can… Stacking it in their locked vaults on pallets in record numbers.April 14, 2024 | msn.comNewcastle hit Tottenham for four to enliven Champions League raceApril 11, 2024 | tmcnet.comSusan G. Komen® Minnesota Race for the Cure Raises Funds for Breast Cancer Patient Care ServicesApril 9, 2024 | msn.comActress Olivia Munn's message after breast cancer: Get risk assessment, know your scoreApril 9, 2024 | msn.comBlack men found to have greater microvascular dysfunction than white men after prostate cancer diagnosisApril 7, 2024 | msn.comReal Madrid will be out for revenge against Man City in the Champions League. Expect fireworksApril 26, 2024 | Stansberry Research (Ad)“Retirement Secret” Showed 995% Gain Last Time We Shared ItCentral Banks Buying Gold in Record Numbers Most folks have completely missed the fact that the world's Central Banks have been quietly gobbling up as much gold as they can… Stacking it in their locked vaults on pallets in record numbers.April 2, 2024 | yahoo.comSharp Memorial Hospital among first in the world to use new robot for surgeriesMarch 31, 2024 | msn.comProstate cancer is the second-leading cancer among men. Here's what to know about itMarch 30, 2024 | bizjournals.comGenentech makes diversity, inclusion gains toward 2025 goalsMarch 27, 2024 | msn.comRace Oncology achieves ‘major milestone’ in progress of lead drug to human trialsMarch 26, 2024 | au.investing.comRace Oncology key asset RC220 passes milestone with manufactured batch confirmed for human IV useMarch 18, 2024 | msn.comJames Ryan in race against time for Leinster Champions Cup tieMarch 18, 2024 | msn.comLeinster star facing race against time to make Champions Cup knock-out tieMarch 17, 2024 | msn.comFulham 3-0 Tottenham: Rodrigo Muniz double deals blow to Spurs in race for Champions LeagueMarch 17, 2024 | au.investing.comRace Oncology appoints Brendan Brown as chief financial officerMarch 13, 2024 | au.investing.comRace Oncology adds international cardiometabolic expert to Scientific Advisory BoardMarch 13, 2024 | msn.comInter Miami races to a 2-0 lead in Champions Cup behind goals from Suarez, MessiMarch 13, 2024 | msn.comInternational cardiometabolic expert to join Race Oncology’s scientific advisory boardMarch 12, 2024 | msn.comPaterson CREW honors friend lost to colon cancer with fundraising 5K runMarch 8, 2024 | finance.yahoo.comNo Solution in Sight, Florida Cancer Specialists & Research Institute, Core Ventures Forge Ahead in Race to Recover from Change Healthcare ShutdownMarch 6, 2024 | finance.yahoo.comBiotech/Oncology Stocks Targeting the Pancreatic Cancer Market - A Race Worth WinningFebruary 28, 2024 | finance.yahoo.comRace Oncology looks to accelerate clinical development of bisantreneFebruary 26, 2024 | msn.comTumor biology may underlie racial differences in certain breast cancer outcomesFebruary 23, 2024 | msn.comNew Duke Study finds breast cancer tumors may differ based on raceSee More Headlines Receive RAC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Race Oncology and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings2/27/2019Today4/26/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeASX SectorMedical Industry Biotechnology Sub-IndustryN/A Current SymbolASX:RAC CUSIPN/A CIKN/A Webwww.raceoncology.com Phone61 3 9097 1656FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)A($0.07) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-11,170,000.00 Net Margins-192.15% Pretax MarginN/A Return on Equity-43.67% Return on Assets-28.46% Debt Debt-to-Equity RatioN/A Current Ratio28.36 Quick Ratio23.71 Sales & Book Value Annual Sales$5.82 million Price / Sales0.00 Cash FlowN/A Price / Cash Flow24.29 Book ValueA$0.12 per share Price / BookN/AMiscellaneous Outstanding Shares164,780,000Free FloatN/AMarket CapN/A OptionableNot Optionable Beta1.37 13 Stocks Institutional Investors Won't Stop BuyingWhich stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.Get This Free Report Key ExecutivesDr. Daniel TillettChief Executive OfficerDr. Peter M. Smith Ph.D. (Age 61)Executive Director Comp: $635Ms. Christina ManfreChief Financial OfficerProf. Tim HammondInterim Chief Scientific OfficerDr. Michelle RashfordChief Medical OfficerMr. Peter Gordon Webse B.Bus (Age 61)FCIS, FCPA, FGIA, M.A.I.C.D., Company Secretary More ExecutivesKey Competitors180 Life SciencesNASDAQ:ATNFW3SBioOTCMKTS:TRSBF45525 (CUR.TO)TSE:CUR60 Degrees PharmaceuticalsNASDAQ:SXTPWAbcamOTCMKTS:ABCZFView All CompetitorsInsidersPhillip(Phil) LynchSold 21,457 sharesTotal: $18,989.45 ($0.89/share)Peter (Pete) SmithSold 440,019 sharesTotal: $374,016.15 ($0.85/share) RAC Stock Analysis - Frequently Asked Questions How were Race Oncology's earnings last quarter? Race Oncology Limited (ASX:RAC) released its earnings results on Wednesday, February, 27th. The company reported ($0.03) earnings per share (EPS) for the quarter. Race Oncology had a negative trailing twelve-month return on equity of 43.67% and a negative net margin of 192.15%. What other stocks do shareholders of Race Oncology own? Based on aggregate information from My MarketBeat watchlists, some companies that other Race Oncology investors own include Mesoblast (MESO), Pilbara Minerals (PLS) and Mount Gibson Iron (MGX). This page (ASX:RAC) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe A.I. story nobody is telling you (Read ASAP)TradeSmithDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsYour Money is Not SafeAmerican AlternativeFed launches fourth dollar overhaulStansberry ResearchThe only accurate crypto trading system I know …Weiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Race Oncology Limited Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
